Investor Presentaiton

Revenue Breakdown By Products Revenue Breakdown 1H2020 1H2019 % of sales ■Clinical Care 36.5% Wound Management 2.6% ■Anesthesia and Surgery 1.3% Medical Testing 1.9% Other Consumables 5.9% ■Orthopaedic Products 16.3% Interventional Products 15.4% Pharma Packaging 15.0% Blood Management 5.0% % of sales ■Clinical Care 42.0% Wound Management 3.3% ■Anesthesia and Surgery 1.3% Medical Testing 1.7% Other Consumables 4.5% Orthopaedic Products 13.8% Interventional Products 16.5% Pharma Packaging 12.7% Blood Management 4.2% Segmental revenues (RMBm) % of revenues 1H2020 1H2019 Medical Device Products 2,459 2,611 % Change (5.8%) 1H2020 1H2019 48.3% 52.8% Clinical Care 1,861 2,077 (10.4%) 36.5% 42.0% Wound Management 133 162 (17.9%) 2.6% 3.3% Anesthesia and Surgery 65 65 0.3% 1.3% 1.3% Medical Testing 99 82 21.3% 1.9% 1.7% Other Consumables 301 225 33.8% 5.9% 4.5% Orthopaedic Products 831 682 21.8% 16.3% 13.8% Interventional Products 783 814 (3.7%) 15.4% 16.5% Pharma Packaging 765 626 22.1% 15.0% 12.7% Blood Management Total WEGO威高 254 210 20.7% 5.0% 5,091 4,943 3.0% 100.0% 4.2% 100.0% 7

View entire presentation